The phenomenon of damage tolerance, whereby cells incur DNA lesions that are nonlethal, largely ignored, but highly mutagenic, appears to play a key role in carcinogenesis. Typically, these lesions are generated by alkylation of DNA or incorporation of base analogues. This tolerance is usually a result of the loss of specific DNA repair processes, most often DNA mismatch repair (MMR). The availability of genetically matched MMRdeficient and -corrected cell systems allows dissection of the consequences of this unrepaired damage in carcinogenesis as well as the elucidation of cell cycle checkpoint responses and cell death consequences. Recent data indicate that MMR plays an important role in detecting damage caused by fluorinated pyrimidines (FPs) and represents a repair system that is probably not the primary system for detecting damage caused by these agents, but may be an important system for correcting key mutagenic lesions that could initiate carcinogenesis. In fact, clinical studies have shown that there is no benefit of FP-based adjuvant chemotherapy in colon cancer patients exhibiting microsatellite instability, a hallmark of MMR deficiency. MMR-mediated damage tolerance and futile cycle repair processes are discussed, as well as possible strategies using FPs to exploit these systems for improved anticancer therapy. Oncogene (2003 Oncogene ( ) 22, 7376-7388. doi:10.1038 Keywords: 5-fluorouracil; 5-fluoro-2 0 -deoxyuridine; 5-fluoro-2 0 -deoxycytidine; futile cycles of repair; DNA damage tolerance; colon cancer treatment Fluoropyrimidine metabolism 5-Fluorouracil (5-FU) was logically designed by Heidelberger et al. (1957) , as a potential tumor-inhibitory drug. There are many excellent reviews about 5-FU available (Weckbecker, 1991; van Laar et al., 1998) . The rationale for its synthesis was based on the enhanced utilization of uracil as a precursor of DNA pyrimidines in a series of transplantable tumors. In this strategy, an antimetabolite was devised in which a fluorine atom was substituted for the hydrogen atom at the fifth position of uracil; it was known that fluorine-substituted organic compounds showed increased toxicity compared to their normal counterparts. Since the atomic radius of fluorine is similar to hydrogen (1.35 Å compared to 1.2 Å ), it was anticipated and indeed confirmed that 5-FU was metabolized in a similar manner as uracil. Once 5-FU was found to have chemotherapeutic activity, its corresponding deoxyribonucleoside derivative 5-fluoro-2 0 -deoxyuridine (FdUrd) was developed (Heidelberger et al., 1958) . 5-FU and FdUrd, used in combination with other agents, are now the most widely used drugs in the treatment of advanced colorectal cancer (CRC) as well as many other cancers.
Fluoropyrimidines (FPs) require uptake and conversion to their active forms before exerting their cytotoxic effects. 5-FU shares the same facilitated transport system as uracil, adenine, and hypoxanthine, whereas FdUrd enters the cell by a distinct facilitated membrane transport mechanism used by purine and pyrimidine nucleosides (Domin et al., 1993; Johnston et al., 1996) . FPs are then converted into fluorinated ribonucleotides and deoxyribonuclotides using the same pathways as those used by uracil and thymine (Figure 1) . FPs have three possible mechanisms of action that are exerted by three different metabolites: 0 -monophosphate (FdUMP) inhibits DNA synthesis by blocking the activity of thymidylate synthase (TS), 5-fluorouridine-5 0 -triphosphate (FUTP) is incorporated into RNA, and FdUrd-5 0 -triphosphate (FdUTP) is incorporated into DNA. The relative contribution of each mechanism to cytotoxicity depends on the FP used, the concentration and duration of exposure, and the system being studied. These mechanisms will be briefly discussed below.
FP effects on TS activity and nucleotide pools
TS catalyses the central reaction in the de novo synthesis of thymine nucleosides and nucleotides (Friedkin, 1973) . It directs the synthesis of thymidylate (dTMP) from deoxyuridylate (dUMP) by transferring a methyl group from its cofactor (5,10-methylene tetrahydrofolate; THF) to the carbon-5 position of dUMP. Normally, a short-lived, covalent ternary complex consisting of TS, dUMP, and THF is formed during this reaction. FdUMP, which is formed from the phosphorylation of FdUrd by thymidine kinase, is a suicide inhibitor of TS. The presence of a fluorine atom instead of a hydrogen at the carbon-5 position of the uracil ring in FdUMP obstructs this reaction (TS cannot break the carbonfluorine bond to allow the methylation), thereby hindering the elimination of THF from the ternary complex and greatly stabilizing this complex (Santi and McHenry, 1972) . As a result, dTMP and ultimately dTTP pools are depleted, resulting in inhibition of DNA synthesis (Fernandes and Cranford, 1986) .
The depletion of dTTP has other effects on the cell (Kunz, 1996) . Through metabolic interconversions and allosteric regulatory mechanisms, fluctuations in any specific deoxyribonucleoside triphosphate (dNTP) may trigger alterations in nucleoside or nucleotide pools. For example, dTTP inhibits CDP and UDP reduction, but stimulates reduction of GDP (Reichard, 1985) . Additionally, the relative dCTP and dTTP levels are controlled by dCMP deaminase (dCMPD) or dCTP deaminase; the activity of these deaminases is stimulated by dCTP and inhibited by dTTP (Reichard, 1988) . However, the overall consequence of these interacting processes usually results in the blockage of dTTP synthesis by FPs, which generally leads to dTTP and dGTP depletion and expansion of dCTP, dATP, and dUTP pools (Maybaum et al., 1981; Sedwick et al., 1981) . For example, treatment with the antifolate methotrexate (an inhibitor of dihydrofolate reductase, the enzyme that generates the THF needed by TS) leads to a decrease in intracellular dTTP of almost two orders of magnitude with a concomitant increase in intracellular dUTP of approximately 1000-fold (Goulian et al., 1980a) . Most significantly, the relative and absolute concentrations of dNTPs are critical for determining the fidelity of DNA replication (Kunz et al., 1994) . Substitution errors by DNA polymerase increase as the concentration of the correct dNTP decreases and that of an incorrect dNTP increases (Roberts and Kunkel, 1988) . Additionally, dNTP perturbations can cause template-primer misalignments that lead to frameshift mutations (Bebenek et al., 1992) .
FP effects on RNA metabolism and processing
FPs can cause general cytotoxicity after conversion to FUTP by their incorporation into RNA in a reaction catalysed by RNA polymerase. FPs can be heavily incorporated into both nuclear and cytoplasmic RNA species and can interfere with normal RNA processing and function (Johnston et al., 1996; Grem, 1997) . Net RNA synthesis is inhibited during and following FP exposure and can be accompanied by alterations in protein levels (Grem, 1996) . The detrimental effect of FP incorporation is different among individual RNA species. The synthesis of ribosomal RNA appears to be the most susceptible, followed by polyadenylated RNA and then transfer RNA (Glazer and Hartman, 1981; Weckbecker, 1991) . Specifically, FPs inhibit the conversion of high M r nuclear RNA species to lower M r ribosomal RNA (Kanamaru et al., 1986) , decrease the stability of messenger RNA by their inhibition of polyadenylation (Grem, 1996) , interfere with normal splicing by incorporating into uracil-rich small nuclear RNA species (Doong and Dolnick, 1988) , and inhibit transfer RNA function by forming covalent complexes with enzymes involved in the post-translational modification of uracil residues (Santi and Hardy, 1987) . In some tissue culture and in vivo models, the extent of FP incorporation correlates with cytotoxicity Glazer and Lloyd, 1982) .
Effects of FP incorporation into DNA
Historically, the incorporation of FdUTP into DNA had been difficult to demonstrate. The availability of tritiated FPs of high specific activity allowed detection of the low levels of FPs in DNA. (Major et al., 1982) . Likewise, FP incorporation into mouse Lewis lung carcinoma and adenocarcinoma-755 tumor cells was noted with an estimated 100 FP moieties incorporated per genome (Boothman et al., 1987a, b) . Two mechanisms that limit the extent of FP incorporation into DNA are discussed below.
FP-mediated DNA damage
Two of the three mechanisms of FP-mediated cytotoxicity act at the level of DNA. Since both the disruption of dNTP pools as a result of TS inhibition and the direct incorporation of FPs into DNA occur concomitantly, it is often difficult to distinguish the relative contribution of one mechanism from the other. In any case, DNAdirected effects of FPs can arise from the following situations: The two most important consequences of these events are the potential mutagenic effects of base analogues/ mispairs in DNA and the fragmentation of DNA created in the cell's attempts to repair these lesions.
The first consequence of FP treatment is mutagenesis. Misincorporation of dUTP in place of dTTP occurs at high frequency in many organisms and can reach almost full substitution without inhibiting replication of some viruses (Takahashi and Marmur, 1963) . dUTP incorporated in place of dTTP is not necessarily miscoding; for example, some bacterial viruses such as PBS1 and PBS2 from B. subtilis (Takahashi and Marmur, 1963) have evolved that tolerate full substitution of dUTP for dTTP in DNA. Furthermore, up to 90% substitution of dUTP for dTTP was demonstrated under conditions of limited growth in multiple mutants of Escherichia coli (el-Hajj et al., 1992) . E. coli normally maintains as much as one dUTP molecule per 200 nucleotides, but the steady-state level of dUTP in DNA of mammalian cells is approximately 10 000 times lower (Goulian et al., 1980b; Nilsson et al., 1980) . Specific damage leading to growth inhibition has not been characterized in DNA repair-deficient E. coli. However, it is clear that misincorporated dUTP can directly interfere with the activity of specific regulatory proteins that bind DNA, as exemplified directly by the abrogation of function due to a single dUTP substitution in a critical binding site at position 13 in the lac repressor (Fisher and Caruthers, 1979) . In spite of the relatively low toxic impact of dUTP substitution for dTTP in some organisms, dUTP misincorporation has the potential to kill mammalian cells if delivered at high concentrations.
5-FU differs from uracil in that it has a fluorine atom at the carbon-5 position instead of hydrogen; analogously, thymine differs from uracil in that it has a methyl group at this position. In standard WatsonCrick hydrogen-bonding patterns between adenine and thymine, the keto group at the fourth position of thymine and the hydrogen of the amino group at the third position of thymine are involved in base pairing; the presence of a fluorine or hydrogen atom at carbon-5 does not disrupt this hydrogen bonding. Thus, incorporation of the dTTP analogue FdUTP into DNA typically results in A:5-FU base pairs. In fact, it has been shown by ultraviolet spectroscopic melting experiments that an A:5-FU base pair is slightly more stable than an A:T base pair; this is presumably due to the unique properties (electronegativity, hydrophobicity, and small size) of the fluorine atom (Habener et al., 1988; Coll et al., 1989) . However, the presence of the electron-withdrawing fluorine atom on the pyrimidine ring could be expected to result in the presence of ionized 5-FU in DNA at physiological pH, which could lead to mispairing with guanine during replication (Freese, 1959; Kremer et al., 1987) . In fact, just as A:5-FU base pairs were found to form pH independent Watson-Crick structures Kremer et al., 1987; Sowers et al., 1987) , ionization of fluorine also allows 5-FU to adopt a Watson-Crick structure when forming a mispair with guanine (Sowers et al., 1988 (Sowers et al., , 1989 . Since FdUrd moities are capable of Watson-Crick mispairing with guanine when incorporated into DNA, treatment of cells with FdUrd has been shown to be both mutagenic (Aebersold, 1979) and oncogenic (Jones et al., 1976) as expected.
The combined effects of dNTP pool imbalance and FdUTP incorporation into DNA also have several consequences on the structural integrity of DNA (Grem, 1997) . Treatment of cells with FPs results in the generation of DNA single-strand breaks (SSBs) and DNA doublestrand breaks (DSBs) (Lo¨nn and Lo¨nn, 1984; Schuetz et al., 1984; Yoshioka et al., 1987) . Thus, DNA appears to become fragmented when it contains non-DNA bases like uracil and 5-FU (Weckbecker, 1991) . The active removal of these bases from DNA by the normal DNA repair mechanisms (see below) is thought to lead to this fragmentation and contribute to the cytotoxicity of FPs (Caradonna and Cheng, 1980; Ingraham et al., 1980 Grem et al., 1989) . In fact, cotreatment of human CRC cells with 5-FU and a DNA polymerase a inhibitor (aphidicolin) blocked incorporation-dependent DNA fragmentation, suggesting that the formation of these DNA breaks was a function of normal DNA repair processes (Lo¨nn et al., 1989) . Additionally, fragmentation may occur via compromised repair processes; proper DNA repair requires the availability of all dNTPs at sufficient concentrations (Parker et al., 1987) . However, DNA fragmentation following FP exposure can also occur in the absence of detectable FdUTP incorporation into DNA (Parker et al., 1987) , and one group reported a correlation between the depletion of dNTP pools and DNA damage (Yoshioka et al., 1987) .
Removal of uridine and FP moieties from DNA
Mechanisms to detect and remove uridine from DNA Uracil (as dUTP) commonly occurs in DNA. Two distinct mechanisms are responsible for dUTP incorporation into DNA, namely the deamination of cytosine to uracil and the direct incorporation of dUTP in place of dTTP as a result of dramatic nucleotide pool imbalances. First, spontaneous deamination is a major problem facing the cell. It has been estimated that approximately 100-500 cytosine residues undergo spontaneous deamination to become uracil per day in each human diploid cell (Lindahl, 1993) . The conversion of cytosine into uracil, which is a fully competent base-pairing partner for adenine, causes a G:C to A:T transition in half of the progeny on replication. Second, the abundance of UTP in the cell required for RNA synthesis as well as modulation of UTP and dUTP pools through exogenous treatments causes DNA polymerase to misincorporate dUTP into DNA. In fact, misincorporation of dUTP in place of dTTP is a much more common occurrence than deamination of cytosine to uracil (Richards et al., 1984) . These events presumably place human cells under high mutational pressure and may have provided the evolutionary impetus for the development of overlapping mechanisms that can detect uracil moieties and remove them from DNA.
As a first line of defense to keep dUTP out of DNA, cells maintain an abundant level of dUTP diphosphohydrolase (dUTPase), an enzyme that effectively prevents accumulation of dUTP pools available to DNA polymerase, unless over-run by very high substrate levels (Caradonna and Adamkiewicz, 1984) . Furthermore, DNA base excision repair (BER) mechanisms appear to be primarily responsible for maintenance of uracilfree DNA. BER is normally an error-free mechanism. The initial recognition/excision enzymes, uracil-DNA glycosylases (UDGs), responsible for this process are among the most studied DNA repair enzymes at the mechanistic and structural levels (Parikh et al., 2000; Pearl, 2000) and will only be briefly described below. Predictably, both dUTPase and many UDGs are active against 5-FU moieties in DNA as well. While the enzyme-catalysed hydrolysis of dUTP and FdUTP are equally efficient, the affinity of human UDG for 5-FU moieties in DNA is 17-fold lower than for uracil (Mauro et al., 1993) .
DNA BER
BER consists of several classes of DNA glycosylases that recognize abnormal and some mismatched DNA bases that cause minor structural changes in DNA (Krokan et al., 2000; Norbury and Hickson, 2001 ). In the primary pathway of BER, a glycosylase catalyses the hydrolytic cleavage of the N-glycosyl bond linking the base to the sugar. This enzymatic cleavage generates an apurinic/apyrimidinic (AP) site and releases the free base from DNA. AP endonucleases and phosphodiesterases then generate a single nucleotide gap containing 3 0 -hydoxyl-and 5 0 -phosphatetermini that permit DNA polymerase to fill the gap. Finally, a DNA ligase seals the remaining nick to complete the repair event.
Enzymes that remove uracil from DNA are collectively called UDGs (Krokan et al., 2001) . These enzymes apparently detect changes in DNA tertiary structure caused by the increased potential for base stacking of thymine versus uracil. These structural differences, reflected in higher thermal stability of dA-dT versus dA-dU copolymers (Gill et al., 1974) , appear to be read by the glycosylases in the major and minor grooves of DNA as they scan double-stranded DNA (dsDNA) for uracil moieties. UDG encoded by the UNG gene accounts for the majority of the total UDG activity. UDG is found in bacteria, yeast, plants, and mammalian cells, and is highly conserved in evolution. It is believed that its primary function is to remove uracil from G:U mispairs resulting from cytosine deamination, although it also removes uracil from A:U base pairs resulting from the misincorporation of dUMP during replication. It is also very effective at removing uracil from single-stranded DNA (ssDNA). UDG is highly specific for uracil in DNA (probably because of an evolutionary requirement to distinguish between uracil and thymine moieties in DNA, which are very similar in structure). In this regard, it shows negligible activity towards the natural DNA bases cytosine or thymine in DNA. However, it does not distinguish between the structural similarities of uracil and 5-FU, and consequently UDG is also effective at removing 5-FU from DNA (see Table 1 ).
Bacterial and mammalian cells also have DNA glycosylases specific for the repair of different types of single-base mismatches. G:T mismatch-specific thymine- DNA glycosylase (TDG) removes thymine from G:T mispairs in a CpG context, although G:T mispairs are found in other sequence contexts and thymine opposite O 6 -methylguanine, cytosine, and thymine are also substrates (Hardeland et al., 2001) . Interestingly, TDG excises uracil from G:U mispairs more efficiently than it excises thymine from G:T mispairs, whereas neither uracil nor thymine in ssDNA or A:U are substrates. Both TDG and MUG (mismatch uracil-DNA glycosylase, the homologous protein in bacteria) have been shown to remove 5-FU from DNA (Hardeland et al., 2001; Liu et al., 2002) . The influence of human TDG on 5-FU incorporation has not yet been examined.
A human DNA repair protein named methylCpG-binding domain 4 (MBD4) was first identified as an MBD-containing protein with a region of similarity to bacterial DNA repair enzymes. It was also independently cloned as methyl-CpG-binding endonuclease 1 by its interaction in a two-hybrid screen with the DNA mismatch repair (MMR) protein MLH1 (although this endonuclease activity now appears to be insignificant) (Bellacosa et al., 1999; Hendrich et al., 1999) . MBD4 acts as a G:T and G:U mismatch-specific thymine and uracil glycosylase. The uracil glycosylase activity of MBD4 is limited to G:U mismatches and does not remove uracil present in ssDNA. MBD4 prefers G:T and G:U mismatches located in the context of methylated or unmethylated CpG sites; since, these mismatches can originate via spontaneous hydrolytic deamination of 5-methylcytosine and cytosine to thymine and uracil, respectively, it appears that MBD4 is involved in the repair of deaminated 5-methylcytosine and cytosine at CpG sites. It was also shown that MBD4 efficiently removes 5-FU in the context of G:5-FU mismatches (Petronzelli et al., 2000) . In fact, transfection of an MBD4 mutant lacking its MBD domain into cells was found to be associated with microsatellite instability (MSI), a hallmark of MMR deficiency (Bellacosa et al., 1999) (see below).
Single-strand-selective monofunctional UDG (SMUG1) was isolated recently (Haushalter et al., 1999) . It is able to excise uracil from ssDNA and from dsDNA in both G:U and A:U base pairs, but showed no activity against G:T mismatches or any range of other possible substrates. Its strong specificity for uracil and its preference for ssDNA substrates led to its designation. SMUG1 was found to have activity against a double-stranded oligonucleotide containing 5-FU:A (Kavli et al., 2002) .
For the present discussion, it is most important to note that each of these processes, if interrupted by either depletion of necessary components or futile repair, may lead to a variety of DNA lesions manifested as unprocessed AP sites or DNA single-stranded gaps of various sizes. Additionally, DSBs and deletions could be generated by the repair by UDG of closely spaced uracil residues on opposite strands of DNA (Dianov et al., 1991) .
DNA MMR
Another important DNA repair pathway in the cell is MMR. It eliminates incorrect base pairs and insertion/ deletion loops that arise during DNA replication, thereby maintaining the integrity of the genome (Fishel, 1998; Kolodner and Marsischky, 1999) . The MMR pathway of E. coli is well characterized and dependent on MutH, MutL, and MutS proteins (Modrich and Lahue, 1996; Modrich, 1997) . It uses the methylation status of the DNA strands to correctly repair only to the nascent (i.e. transiently unmethylated) strand. The proteins involved in mammalian DNA MMR share significant structural similarities to bacterial MMR proteins. There are many comprehensive reviews on bacterial MMR and its comparisons with the more complicated MMR systems of eucaryotes (Hsieh, 2001; Peltomaki, 2001 ). Here, we will focus not on general MMR processes, but rather on damage detection, tolerance, and cell responses to damage initiated by MMR processes.
The process of MMR occurs in several principal steps: mismatch/loop recognition and assembly of MMR proteins, degradation of the error-containing strand in a strand-specific manner, unscheduled DNA synthesis, and finally ligation. A heterodimer of MSH2-MSH6 or MSH2-MSH3 (MutS homologues) is responsible for mismatch recognition (Modrich and Lahue, 1996) . MSH2-MSH6 heterodimers detect mispairs and small loops; MSH2-MSH3 heterodimers primarily detect small loops. ADP to ATP nucleotide exchange occurs and induces a conformational change in these MutS heterodimers that reduces its affinity for the damage site and allows the complex to diffuse freely along the DNA in an ATP hydrolysisindependent manner (Fishel, 1999; Gradia et al., 1999; Wilson et al., 1999) . This step is referred to as the 'sliding clamp'. Following lesion detection, DNA lesion excision then requires the interaction of the MLH1-PMS2 heterodimer (MutL-related proteins) with the MSH2-MSH3/6 complexes. The details of this mechanism are still poorly understood. The MLH1-containing complex presumably acts as a 'molecular matchmaker' (Sancar and Hearst, 1993) and allows for the interaction of numerous other proteins to form a higher-order complex that is involved in excision of a large fragment of DNA (up to 1000 base pairs) that contains the mismatch. The other factors that comprise this large MMR complex include exonucleases and endonucleases (exonuclease-1 and flap endonuclease-1, respectively) and replication factors (DNA polymerase d, proliferating cell nuclear antigen, replication protein A, and replication factor C) (Bellacosa, 2001) . DNA synthesis and ligation complete the repair process. The exact manner by which all of these steps occur in terms of the order of events and the required level of association of protein complexes is at present poorly understood, but currently under intense investigation. A discussion of current theories regarding these mechanisms is beyond the scope of this review.
MMR and drug resistance
Loss of functional MMR is associated with cancer and drug resistance. Thus, understanding the cellular mechanisms of loss of MMR activity, developing ways to restore MMR, and/or developing treatment regimens that target MMR-deficient cells are important. The first indication of the importance of MMR in protecting against human disease was found during the investigation of hereditary nonpolyposis CRC. These studies have convincingly demonstrated a direct cause and effect relationship between mutations in MMR genes (in particular, hMLH1 and hMSH2) and the development of MSI. MSI is an indication of faulty MMR and genetic instability. The proteins required for a functional MMR system are responsible for detecting DNA damage and mediating induction of apoptosis, therefore controlling lethality.
Cells deficient in MMR are more resistant to the cytotoxic effects of several DNA-modifying agents than cells that are MMR proficient (Fink et al., 1998; Lage and Dietel, 1999; Jiricny and Nystrom-Lahti, 2000; Jacob et al., 2001) . This is especially true of methylating agents (such as N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG), N-methyl-N-nitrosourea, procarbazine, and temozolomide) and the modified purine antimetabolite 6-thioguanine (6-TG), and much more modestly true of agents such as cisplatin and doxorubicin (Karran, 2001 ). In fact, this was first observed in E. coli strains treated with MNNG (Karran and Marinus, 1982) , and later extended to eucaryotic cells. In MMR-deficient cells, exposure to certain alkylating agents result in the accumulation of DNA damage, but not cell death. This phenomenon is often referred to as 'damage tolerance' and could allow both the unchecked development of carcinomas and their subsequent resistance to therapies.
MMR-mediated futile cycling
A model of 'futile cycles of repair' has been proposed to explain the relationship between MMR and induction of apoptosis (Karran and Bignami, 1994; Karran and Hampson, 1996; Karran, 2001) . In this theory, MMRproficient cells treated with some alkylating agents or antimetabolites (such as 6-TG or FPs) respond by removing mismatched bases opposite damaged bases. However, the continued presence of antimetabolites or an abundance of damaged bases leads to further misincorporation events and repeated rounds of MMR. This process is greatly exacerbated by the natural mechanism of MMR, whereby a large tract of one DNA strand (approximately 1 kb) is typically removed each time even a single mispair is repaired by MMR. These additional, now futile, cycles of MMR ultimately lead to the generation of DNA strand breaks and cell death. As a consequence of repeated MMR activities in E. coli, it was suggested that the MutH endonuclease itself might be responsible for producing a DSB that ultimately results in cell death by making a second incision on the opposite strand of heteroduplex DNA at an unmethylated d(GATC) site (Glickman, 1982; Au et al., 1992) . Other models that attempt to explain increased cell death due to MMR activity suggest that repeated rounds of MMR action due to futile cycles of repair lead to a collision of MMR enzymes with BER or DNA replication enzymes (Davis et al., 1998) ; however, evidence in support of this theory is lacking. Finally, the proteins of the MMR system may recognize damaged DNA and directly trigger a signal transduction cascade that activates the apoptotic or necrotic cell death responses in cells. All of the above models attempt to explain how cells with MMR defects acquire selective growth advantages, acquire mutations, and thus become tumorigenic, whereas MMR-competent cells respond to the same DNA lesions with lethal consequences. These MMR-dependent responses appear to support the theory that cell death, as opposed to survival with high mutagenic consequences, is evolutionarily preferable in multicellular organisms (Boothman et al., 1988) .
MMR-mediated signaling
Cell cycle arrests are postulated to allow cells greater time to repair DNA damage and/or allow the elimination of severely damaged cells to prevent tumor formation in mammalian cells (Boothman et al., 1988; Hartwell and Kastan, 1994) . The responses of MMRcompetent cells to specific types of DNA-damaging agents appear to highlight both of these responses, and offer the best 'proof of principle' of these hypotheses in human cells. Boland and his co-workers first reported differential cell cycle G 2 checkpoint arrest between matched MMR-proficient and -deficient cells treated with MNNG and later 6-TG (Koi et al., 1994; Hawn et al., 1995) . These investigators proposed that G 2 arrest would allow cells time to repair lesions created during replication prior to entering mitosis, resulting in greater mutational avoidance. This fits the notion that MMR is involved in postreplicative DNA repair (Muller and Fishel, 2002) . However, further examination revealed that MMR status only impacts cell cycle progression following exposure to certain DNA-damaging agents. One pertinent question concerns the origin of the signal for this cell cycle checkpoint arrest. Many theories have been postulated to explain the MMR-dependent differential cell cycle signaling that has been noted after exposure to some, but not all, DNA-damaging agents; these are discussed below.
Role of p53 protein family members
It has been suggested that MMR mediates the stabilization of the p53 tumor suppressor protein, and that this is responsible for G 2 arrest checkpoint responses (Stewart and Pietenpol, 2001 ). Some theories hold that both p53 and p73 are involved (Strano et al., 2001) . Both p53 and its homologue, p73, are activated after DNA damage and act as transcription factors involved in regulating genes involved in cell cycle arrest or apoptosis (Strano et al., 2001) . The role of post-translational modifications Role of MMR in response to fluoropyrimidines M Meyers et al involved in p53 (and p73) stabilization and transactivation are complex. p53 can be acetylated and/or phosphorylated at many amino-acid residues, and the coordinated actions of these various modifications allow for differential regulation of downstream cell cycle and apoptotic responses. Interestingly, p53 has been shown to be selectively phosphorylated in an MMR-dependent manner after MNU or MNNG treatments at two residues, serine-15 and serine-393 (Duckett et al., 1999) ; we have found similar results (Wagner et al., in preparation). These phosphorylation events lead to stabilization of p53 by disrupting its interaction with the human homologue of the mouse double minute-2 protein, which normally targets p53 for degradation (Stewart and Pietenpol, 2001 ). However, our lab (Davis et al., 1998) and others (Hickman and Samson, 1999; Lin et al., 2000) have shown that p53 is dispensable for G 2 arrest, apoptosis, and loss of colony-forming ability after treatment with other DNA-damaging agents. Loss of p53 by stable transfection of both matched MMRcompetent and -deficient cells with the human papillomavirus E6 protein, which binds to and destabilizes p53 by enhancing its degradation, had little effect on survival (Davis et al., 1998) . These experiments demonstrate that MMR-dependent cell cycle arrest and apoptosis probably occur independently of p53 status. However, contradictory results have been reported by other groups (Bunz et al., 1999; Vikhanskaya et al., 1999) .
Although p53 status does not appear to be required for G 2 arrest responses, its activation in an MMRdependent manner can result from intracellular signaling responses that originate from DNA lesions detected (or created) by MMR (Figure 2) . The selective phosphorylation of serine-15 on p53 appears to be indicative of upstream activation of ATM (mutated in ataxia telangiectasia) and/or ATR (ATM and Rad3 related), which are phosphatidylinositol 3-kinase-related (PI-3-K) protein kinases (Abraham, 2001; Durocher and Jackson, 2001; Bernstein et al., 2002) . In fact, a recent study has shown that MNNG activates ATM, and wortmannin (a PI-3-K inhibitor) effectively blocks phosphorylation of serine-15 of p53 (Adamson et al., 2002) . Our own lab and others (Carethers et al., 1996) have found that caffeine over-rides MMR-dependent G 2 arrest mediated by MNNG in the HCT116 model cell system (Wagner et al., in preparation). Although the mechanism by which caffeine abrogates G 2 arrest responses is not entirely clear, inhibition of ATM by this agent has been proposed. It is also entirely possible that these responses are independent of ATM or ATR.
Since p53 may not influence MMR-dependent cell cycle arrest and apoptosis after exposure to specific DNA-damaging agents, a role for p73 may be indicated. p73 may be stabilized in an MMR-dependent manner after treatment with cisplatin, a bifunctional alkylating chemotherapeutic agent that produces platinum-DNA adducts (Gong et al., 1999) . This stabilization seems dependent on acetylation of key residues by the c-Abl nonreceptor tyrosine kinase, whose activation also seems dependent on ATM Shafman et al., 1997; Agami et al., 1999; Yuan et al., 1999; Costanzo et al., 2002) . The MMR and c-Abl pathway also may be linked to the JNK1, c-junactivated kinase pathway (Nehme et al., 1997 (Nehme et al., , 1999 . However, a clear demonstration of a role for p73 in MMR-dependent G 2 arrest responses has yet to be established.
One candidate protein speculated by our laboratory to be involved in the MMR-dependent G 2 arrest is the breast cancer susceptibility protein 1, BRCA1. BRCA1 is involved in G 2 cell cycle arrest and is thought to interact downstream of ATM/ATR, playing a role in both cell cycle arrest and homologous DSB repair. In a manner similar to p53, BRCA1 may be hyperphosphorylated and thus activated by ATM/ATR, allowing it to act as a transcription factor for several downstream cell cycle arrest proteins, such as p21
, the growth-arrest and DNA-damage-inducible 45 gene product (GADD45), and 14-3-3s (Wang et al., 2000; Venkitaraman, 2002) . However, only GADD45 seems to be differentially induced in an MMR-dependent fashion in response to FP exposures (Meyers et al., 2001) . Interestingly, BRCA1 also appears to form a stable inactive complex with c-Abl that becomes activated by ATM following the formation of DNA damage, specifically DSBs. The BRCA1-c-Abl complex is believed to dissociate due to the activation of c-Abl by damage and its phosphorylation, releasing c-Abl and allowing for downstream signaling (Foray et al., 2002) . A direct interaction between the MMR protein hMSH2 and BRCA1 has been observed and both are proposed parts in a multiprotein complex involved in DNA damage recognition and repair known as the BRCA1-associated genome surveillance complex (Wang et al., 2000 (Wang et al., , 2001 ). Our laboratory is currently investigating these hypotheses. However, it is not known how MMRdependent detection of specific lesions can activate the ATM/ATR kinases. Two theories have been proposed to explain the MMR-dependent cellular responses to specific DNA damage (Figure 2 ). In the first theory, MMR detection of DNA lesions leads to the creation of DSBs caused by futile cycles of repair or repair-replication fork collisions (Davis et al., 1998) . The other theory states that MMR can act as a DNA damage sensor and directly signal cell cycle arrest, although evidence for a direct interaction between MMR and ATM or ATR has not been established. The aggregate of data seems to support the theory that MMR detection of DNA lesions leads to the formation of DSBs after FP exposure (Meyers et al., 2001) , although current technology allows detection of DSBs only at lethal drug concentrations. However, we speculate that MMR detects DNA lesions and allows repetitive rounds of futile cycle repair via the formation of multiple sliding clamp complexes in the vicinity of the originally detected DNA lesion. These repetitive MMR events result in fragile DNA, creating DSBs. The formation of DSBs then leads to the activation of ATM and/or ATR or other signal transduction responses leading to G 2 arrest. Activation of these signal transduction processes then results in G 2 arrest responses, with p53 (p73) activation possibly required for apoptotic, but not overall survival responses (Davis et al., 1998) .
Role of MMR in detecting and responding to FP moieties in DNA
We investigated the role of MMR in the cellular responses to FPs using various genetically matched cells containing altered MMR proficiency (Meyers et al., 2001) . Clonogenic assays were performed to determine the survival of HCT116 human CRC (MMR-deficient) compared to HCT116 3-6 (MMR-proficient) cells following continuous treatments with various doses of 5-FU or FdUrd. HCT116 cells were 18-fold more resistant to 7.5 mm 5-FU and 17-fold more resistant to 7.5 mm FdUrd compared to HCT116 3-6 cells. Similarly, in a mouse system (Buermeyer et al., 1999) in which spontaneously immortalized embryonic fibroblasts from the MLH1 À/À mouse were transfected with hMLH1 cDNA (ME-10) or empty vector (CT-5), ME-10 cells were threefold more sensitive to 10 mm FdUrd following a 2-h exposure compared to CT-5 cells. In both systems, subsequent incubation with thymidine was able to rescue this cytotoxicity, whereas incubation with uridine did not, indicating that the FP-mediated cytotoxicity was DNA directed. The same phenomenon was observed in both human and mouse cells deficient in the other major MMR protein, MSH2 (Meyers et al., in preparation) .
To examine the influence of MMR pathways on cell cycle checkpoint responses, changes in cell cycle distribution of MMR-proficient and -deficient cells following exposure to FdUrd were examined (Meyers et al., 2001) . HCT116 or HCT116 3-6 cells were synchronized by confluence arrest and treatment with low serum. Arrested cells were released by low-density replating and treated with FPs immediately before entry into S phase (i.e. at 16 h after release from growth arrest). Only HCT116 3-6 cells showed extensive G 2 arrest responses after treatment with 0.25 mm FdUrd. At higher doses, the G 2 arrest was equivalent in both cell lines and persisted for at least 72 h. Likewise, MMRproficient ME-10 cells and MSH2-expressing cells demonstrated greatly enhanced G 2 arrest responses following similar FP exposures (Meyers et al., unpublished observations) .
Finally, HCT116 and HCT116 3-6 cells were treated with various doses of FdUrd continuously for 72 h, then DSB formation was assayed using pulsed-field gel electrophoresis. In both cell lines, treatment with as little as 2.5 mm FdUrd resulted in the appearance of DSBs. However, the degree of fragmentation was more pronounced in MMR-proficient HCT116 3-6 cells. Interestingly, the DNA fragmentation did not appear to reflect apoptosis simply, since both HCT116 and HCT116 3-6 cells treated in this manner had identical, low levels of apoptosis (7.570.5%) as quantified by a modified terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay. Based on our published data, we propose the model shown in Figure 3 to represent how MMR processes may mediate cellular responses to FP treatment.
Although both BER and MMR are clearly involved in responses to FP-induced DNA damage, direct interfaces between BER and MMR have not been demonstrated, other than the two-hybrid interaction reported between MLH1 and MBD4 previously mentioned (Bellacosa et al., 1999) . BER is clearly involved in initial responses to FP-induced lesions, since both uracil and 5-FU moities are recognized and excised by UDGs. Our own data indicate that neither the hMSH2-3 or MSH2-6 complex recognizes an A:5-FU base pair in a DNA oligonucleotide by band shift and ATPase activity assays (Meyers et al., in preparation) . However, G:5-FU moieties are recognized. These data suggest that MMR does not process A:5-FU lesions; they are probably handled by BER. In contrast, MMR appears to process the potentially more mutagenic G:5-FU lesions. Alternatively, MMR could further play a major role following (and in conjunction with) BER's response to For example, in the latter case, one or more unrepaired AP sites might destabilize DNA ends at break sites, leading to transient formation of mispaired DNA loops. In such cases, MMR could convert relatively small incompletely repaired patches created by BER to large repair patches, thus enhancing the phenomenon of futile cycling by greatly increasing the probability that sites of initial dUMP or FdUMP incorporation are not correctly repaired.
The probability that the second scenario may occur in mammalian cells is consistent with observations of Duker et al. (1982) showing that AP sites antagonize their own repair if closely spaced in DNA. Thus, under conditions leading to high dUMP and/or FdUMP incorporation densities, mispaired loops involving AP sites could be more common than anticipated at SSBs, providing lesion sites that are recognized by MMR and leading to a cascade of events resulting in progressively larger repair patches in DNA until completion of normal repair processes becomes impossible. The latter model is attractive because it might be more likely to result in accumulation of SSBs at high enough densities on both DNA strands to lead to DSBs and apoptotic signaling (Taverna et al., 2001) . In both models, however, abrogation of checkpoint responses in MMR-defective cells could permit lesion bypass to occur before unacceptable lesion densities accumulate from redundant attempts to repair lesions under conditions where they continuously reform. This could then explain the higher tolerance of MMR-defective cells for FPs. Regardless of the mechanism, MMR appears to be involved in a major cell cycle checkpoint response specifically at G 2 , where it appears to recognize some sort of DNA damage and then prevent cell cycle progression until FP-induced lesions are repaired or cell death occurs (Meyers et al., 2001) .
Clinical applications
The responses of MMR-competent compared to MMRdeficient cells to FPs have direct clinical relevance, since nearly 15% of all CRC may be attributed to the loss of MMR and FP antimetabolites remain standard drugs used for the treatment of CRC. Cell culture studies using other 5-substituted halogenated thymidine analogues (such as 5-bromo-2 0 -deoxyuridine and 5-iodo-2 0 -deoxyuridine) do not indicate that there is any survival difference between MMR-proficient and -deficient cells; however, the greater degree of incorporation of these antimetabolites into the DNA of MMR-deficient cells make these drugs attractive agents for selective radiosensitization following treatment with ionizing radiation (Berry et al., 1999 (Berry et al., , 2000 . Likewise, many contemporary combined treatment modalities were designed to increase the DNA-level cytotoxicity of 5-FU (e.g. by increasing the production of FdUMP and/or the stability of FdUMP-THF-TS) with the anticipation, and realization to some extent, of increased tumor selectivity. We suggest that such DNA-targeted cytotoxicity may be contraindicated when treating patients with MSI tumors. In these circumstances, treatment may result in a cytotoxic response in normal cells with increased resistance to drug treatment due to damage tolerance in tumors that lack MMR activity. Furthermore, analogous to studies observed in bacteria (LeClerc et al., 1996; Mao et al., 1997) MMR-deficient cells could, in fact, be selected for by such DNA-directed FP treatments. In addition, treatment of MMR-deficient tumors may harbor an elevated level of mutation due to FP-induced DNA lesions. Survival of cells with accumulated mutations could result in increased tumor heterogeneity and selection for more malignant and invasive tumor cells. Indeed, two recent clinical reports have found that standard, 5-FU-based chemotherapy given to colon cancer patients with high levels of MSI did not result in a significant survival advantage (Goel et al., 2003; Ribic et al., 2003) .
FdCyd: a new therapeutic approach for treatment of MMR tumors
Although not yet tested in humans, 5-fluoro-2-deoxycytidine (FdCyd) has exhibited promise for tumor therapy in animal models (Mekras et al., 1984; Boothman et al., 1987a) . FdCyd antimetabolites can be acted upon by deaminases specifically elevated in CRCs, thereby effectively delivering FdUrd to DNA in tumors (Mekras et al., 1984; Kaysen et al., 1986; Boothman et al., 1987b) . In fact, Mekras et al. (1984 Mekras et al. ( , 1985 showed that FdCyd was more effective on a molar basis in vivo than 5-FU or FdUrd and exhibited more tumor cell-directed cytotoxicity. This higher efficiency was partially (Mekras et al., 1985; Boothman et al., 1987a) . Subsequent studies showed that fluorinated cytidine compounds, when modulated with the dCyd deaminase (dCydD) inhibitor tetrahydrouridine (H 4 Urd), could deliver as much as three to four orders of magnitude higher levels of FdUMP to tumor tissue versus normal tissue (Mekras et al., 1984; Boothman et al., 1987a, b) . This occurs because H 4 Urd can inhibit the conversion of FdCyd to FdUrd and instead channel its conversion to FdCMP, whereby (following deamination) it is converted to FdUMP at high levels, causing greater TS inhibition and cytotoxicity than FdCyd alone (see Figure 4) . (Mekras et al., 1984 (Mekras et al., , 1985 Boothman et al., 1985; Kaysen et al., 1986 ). In addition to being able to modulate FdCyd metabolism in tumor tissue selectively, FdCyd is a powerful hypomethylating agent. As shown in Figure 4 , after its incorporation into DNA, FdCyd has the potential to modulate promoter CpG methylation through its inhibition of cytidine methylases (Newman and Santi, 1982) . In this regard, the FdCyd moiety may form covalent bonds with DNA methylase following incorporation into DNA and can exhibit higher stability in DNA than the more extensively studied DNA methylase inhibitors, 5-azacytidine (AzaC) and 5-aza-2 0 -deoxycytidine (AzadC) (Newman and Santi, 1982; Osterman et al., 1988) . This dual activity potential of FdCyd makes it of special interest to explore the efficacy of FdCyd for treatment of a significant subset of cancers that are defective in MMR due to aberrant methylation of the hMLH1 promoter. This subgroup of sporadic CRCs represents up to 15% of total CRCs (Herman et al., 1998) and a significant proportion of gastric cancers (Fleisher et al., 2001) . A number of studies have demonstrated that CpG methylation-dependent MMR defects in colon and endometrial tumor cells can be transiently reversed by exposure to AzaC and AzadC (Kane et al., 1997; Herman et al., 1998; Veigl et al., 1998) . These agents, like FdCyd, work by disrupting promoter methylation patterns seen in CpG sequences residing in the hMLH1 promoter and transiently restoring the expression of functional hMLH1. Since FdCyd can be modulated by dCMPD and dCydD inhibitors to incorporate FdCTP as well as FdUTP into DNA, it may be of special interest to explore the efficacy of FdCyd for treatment of MMR-defective tumors aberrantly silenced for hMLH1 expression. Specifically, FdCyd has the potential to both induce hMLH1 expression through its incorporation as FdCTP into DNA and to kill MMR-competent cells by TS inhibition and effectively inducing incorporation of FdUTP and dUTP into DNA.
Unresolved issues and future directions
Since the cell systems used in our laboratory vary only in specific MMR protein expression, it seems plausible that DNA lesions account for the survival difference between MMR-proficient and the more resistant MMRdeficient cells following FP exposure. Unfortunately, it
has not yet been established whether FdUrd-induced incorporation of dUTP is required alone or in combination with incorporation of FdUTP for manifestation of FdUrd-induced cytotoxicity. In this regard, it is important to note that several approaches that might answer this important question are available. For example, in mammalian cells, dUMP levels can be potentially downregulated by concentrating inhibition strategies on three critical enzyme activities that determine dUMP levels in cells: dUTPase (McIntosh and Haynes, 1997), RR (Kashlan et al., 2002) , and dCydD (Bianchi et al., 1987) . Unfortunately, genetic antisense RNA or other strategies that might be used to inhibit dUTPase would increase the size of dUTP pools that result in dUMP incorporation into DNA, and also would increase the probability that both FdUTP and dUTP would be incorporated into DNA (Caradonna and Cheng, 1980; . It may also be possible to interdict de novo synthesis of dUTP precursors by manipulating intracellular dNTP levels that regulate the ability of RR to produce deoxynucleotide precursors of dUMP. However, these strategies are complicated (Kashlan et al., 2002) . Finally, dUMP and consequent dUTP levels can also be directly downregulated by inhibiting dCMPD and dCydD (Bianchi et al., 1987) . For example, it should be possible to reduce dUTP misincorporation relative to that of FdUTP by treating cells with a combination of FdUrd and H 4 dUrd (Boothman et al., 1987a, b) . Such an approach should have two consequences. First, FdUTP incorporation into DNA will be augmented through the ability of FdUMP to inhibit TS and consequently facilitate the efficiency of its own incorporation through reduction of dTTP pools. Second, dUTP misincorporation should be reduced since dCydD activity makes important contributions to intracellular dUMP pools. Therefore, the levels of uracil moieties in DNA should be reduced in cells treated with 5-FdUrd and dCydD inhibitors relative to levels achieved in cells treated with FdUrd alone. This approach should be useful in dissecting the relative importance of dUTP misincorporation to the toxic effects of FdUrd. Since all components of the pathways leading to FdUrd-induced toxicity at the DNA level are interactive, results of various drug combinations must be carried out in the context of careful analysis of nucleotide pool levels. However, scrutiny of these inter-relationships should be rewarded with a much clearer understanding of the mechanism leading to FP-induced cytotoxicity, as well as the promise to improve therapy of patients afflicted with MMR-deficient tumors.
